查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1371943

2030 年生物可吸收植入物市场预测：按产品类型、材料类型、用途、最终用户和地区进行的全球分析

Bioresorbable Implants Market Forecasts to 2030 - Global Analysis By Product Type, Material Type, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球生物可吸收植入物市场规模为 1,113 亿美元，预计到 2030 年将达到 2,060.8 亿美元，预测期内年复合成长率为 9.2%。

可生物吸收植入物是由最终分解并被人体吸收的材料製成的医疗设备。植入物的生物可吸收成分逐渐扩散到体内，无需进行修復手术即可去除人造材料。生物可吸收植入物有人造材料和天然材料。生物可吸收植入物减少了金属植入物所需的翻修手术的需要。生物可吸收植入物以支架的形式用于心血管应用，以螺丝和销钉的形式用于治疗骨折和脚踝手术，以网的形式用于治疗疝气和骨盆器官脱垂。

根据世界卫生组织 (WHO) 2017 年 5 月的情况说明书，2016 年约有 1,790 万人死于心血管疾病，占全球死亡人数的 31%。

对生物可吸收骨支架的需求不断增长

骨骼损伤可以使用生物可吸收骨支架进行修復。生物可吸收骨支架逐渐被人体吸收，使新的骨组织发育。由骨折、肿瘤或感染疾病引起的骨缺损可用生物可吸收骨支架取代。此外，支架可作为新骨组织发育的支撑结构，并最终被吸收到体内。骨移植是从身体的一个部位移植到另一个部位的骨碎片，可以使用生物可吸收骨支架来稳定。此支架有助于保持骨移植物的位置，直到它融入周围的骨头。可以使用生物可吸收骨支架来治疗缺失的骨骼，以刺激骨骼生长。因此，市场成长的需求不断增加。

材料限制和成本

与不可吸收植入物相比，生物可吸收植入物的材料选择目前受到限制。儘管经常使用聚合物和陶瓷，但它们的机械性能、降解率和加工方法可能不适合所有用途。此外，由于材料成本、製造程序和法规限制的增加，生物可吸收植入物可能比不可吸收植入物更昂贵。医疗保健专业人士、付款人和患者都在权衡生物可吸收植入物的成本效益，以及它们的使用方式会产生影响。因此，这些都是市场拓展的主要障碍。

加大研发投入

生物可吸收植入物是广泛研究和开发的主题。可生物吸收的植入物可以减少发炎和感染等问题的机会。这是因为它是使用对人类安全的材料建造的。此外，透过减少翻修手术的需要，生物可吸收植入物可以改善患者的治疗效果。这是因为随着生物吸收的进行，新的组织会在这个位置形成。随着时间的推移，生物可吸收植入物可能会变得比传统植入物更便宜。增加的研发资金正在创造新的、更好的生物可吸收植入物。这些要素正在促进市场成长。

缺乏意识和教育

外科医生、其他专家和全科医生可能不熟悉或不了解生物可吸收植入物。缺乏知识可能会导致不愿意或有限地采用这种新兴技术。缺乏知识可能会导致人们在使用生物可吸收植入物之前犹豫不决或不愿意改变公认的规范。然而，与不可吸收植入物相比，可能存在强度、寿命和长期功能的担忧。如果没有必要的培训和资讯，医疗保健提供者可能不愿意提案或使用生物可吸收植入物，这阻碍了市场的成长。

COVID-19 的影响

COVID-19 大流行对全球生物可吸收植入物市场产生了重大影响。由于疫情爆发导致医院推迟了整形外科手术等选择性手术，对生物可吸收植入物的需求受到限制。 COVID-19 透过限制化学和材料行业的运作方式袭击了全球市场。此外，供应链中断和原材料采购挑战严重限制了生物可吸收植入物市场。儘管存在这些短期挑战，生物可吸收植入物市场预计在未来年度将大幅扩张。

陶瓷领域预计将在预测期内成为最大的产业

预计陶瓷领域将占据最大份额。陶瓷是一种无机非金属材料，具有特殊性能，非常适合生物可吸收植入物的特定用途。陶瓷因其优异的机械强度、生物相容性和骨传导性而广泛应用于生物可吸收植入物中。陶瓷材料可作为骨骼再生的支架，帮助植入物融入周围组织。陶瓷生物可吸收植入物经常用于需要强大机械性能和结构支撑的情况。

生物网格领域预计在预测期内年复合成长率最高。

预计生物网格领域将在预测期内出现良好的成长。这种可植入材料被称为“生物网”，是利用人类尸体捐赠者或动物组织等生物资源製成的。在这些网格的製造和加工过程中，支持结构完整性并帮助组织整合的细胞外基质（ECM）被保留，同时细胞成分被移除。由于生物网是由天然材料製成的，因此人体通常能够很好地耐受它们。与合成材料相比，它不太可能引起免疫反应或排斥反应。身体有能力重建并最终重新吸收生物网。网片逐渐劣化并被新鲜组织取代，从而形成自然修復过程。

比最大的地区

由于心血管疾病高患病和老年人口不断增长要素，北美在预测期内占据了最大的市场占有率，预计这将增加骨质疏鬆症和骨关节炎病例的数量。此外，对整形外科植入物的需求不断增加，以及不断开拓先进技术来提高现代治疗方法和设备的临床表现，预计将在预测期内推动北美市场的成长。

复合年复合成长率最高的地区：

由于对生物可吸收植入物的高度认识，预计亚太地区在预测期内将实现盈利增长。亚太地区高龄化率高，人口不断增加。结果，患有骨质疏鬆症和骨关节炎等慢性疾病的人数不断增加。生物可吸收植入物可用于治疗这些疾病并改善患者的生活品质。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和年复合成长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第1章执行摘要

第2章前言

  • 概述
  • 利害关係人
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第3章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第5章全球生物可吸收植入物市场：依产品类型

  • 支架
    • 週边动脉支架
    • 冠状动脉支架
    • 非血管支架
      • 胆管支架
      • 食道支架
  • 生物网
  • 固定装置
  • 吸水网
  • 吸收带
  • 可吸收支架
  • 吸收繫绳

第6章全球生物可吸收植入物市场：依材料类型

  • 陶瓷
  • 金属的
  • 聚合物
    • PGA（聚乙交酯）
    • 共聚物
    • PLA（聚乳酸）
  • 其他材质类型

第7章全球生物可吸收植入物市场：依用途

  • 整形外科
  • 心血管
  • 一般外科
  • 整容手术
  • 颅骨
  • 牙科手术
  • 血管外科

第8章全球生物可吸收植入物市场：依最终用户分类

  • 专科诊所
  • 医院
  • 门诊手术中心
  • 其他最终用户

第9章全球生物可吸收植入物市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第10章进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第11章公司简介

  • Medtronic Plc
  • Dentsply Shiroma.
  • Boston Scientific Corporation
  • Meryl Life Sciences Pvt. Ltd.
  • Stryker Corporation
  • Smith & Nephew Plc
  • KLS Martin
  • Wright Medical Group
  • Biotronik Ltd
  • Syntellix AG
  • JW Medical Systems LTD
  • Q3 Medical Devices Limited.
  • Orbusneich Medical.
  • Depuy Synthes
  • Bioretec Ltd
  • Conmed Corporation
  • Zimmer Biomet Holdings, Inc.
Product Code: SMRC24000

According to Stratistics MRC, the Global Bioresorbable Implants Market is accounted for $111.3 billion in 2023 and is expected to reach $206.08 billion by 2030 growing at a CAGR of 9.2% during the forecast period. Bioresorbable implants are medical devices that are made from materials that are eventually broken down and absorbed by the body. The implants' bioresorbable components gradually diffuse in the body, negating the need for a second operation to remove the artificial material. The bioabsorbable implants can be made of both artificial and natural materials. The bioabsorbable implants will reduce the need of second surgery which is required in the case of metallic implants. The bioabsorbable implants are used in many applications such as cardiovascular in the form of stents, screws and pins are used in orthopedics for the treatment of fractures and ankle surgeries, also the implants are used in the form of mesh for the treatment of hernia and Pelvic organ prolapsed.

According to the World Health Organization (WHO) May 2017, factsheet around 17.9 million people died due to cardiovascular disease in 2016, accounting for 31% of all worldwide deaths.

Market Dynamics:

Driver:

Rising demand for bioresorbable bone scaffolds

Bone injuries can be repaired using bioresorbable bone scaffolds. They are progressively absorbed by the body, allowing for the development of new bone tissue. Bone deficiencies brought on by fractures, tumours, or infections can be filled with bioresorbable bone scaffolds. Additionally, the scaffold acts as a support structure for the development of new bone tissue, and it is eventually absorbed by the body. Bone grafts, or fragments of bone that are transplanted from one area of the body to another, can be stabilised using bioresorbable bone scaffolds. The scaffold aids in maintaining the position of the bone graft until it is assimilated into the surrounding bone. Insufficient bone can be treated with bioresorbable bone scaffolds to encourage bone development. Thus, there is an increasing demand for market growth.

Restraint:

Material limitations & cost considerations

In contrast to non-resorbable implants, the selection of materials for bioresorbable implants is currently constrained. Although polymers and ceramics are frequently used, not all applications may be suited to their mechanical characteristics, rates of degradation, or processing methods. Additionally, due to the increased cost of materials, manufacturing procedures, and regulatory restrictions, bioresorbable implants may be more expensive than non-resorbable implants. Healthcare professionals, insurers, and patients all heavily weigh the cost-effectiveness of bioresorbable implants, which can have an impact depending on how they are used. Therefore, these are significant barriers to the market expansion.

Opportunity:

Rising investment in research and development

Bioresorbable implants are the subject of extensive research and development. They can lower the possibility of problems like inflammation and infection. This is due to the fact that they are constructed using substances that are safe for the human body. Additionally, by lowering the need for revision surgery, bioresorbable implants can enhance patient outcomes. This occurs as a result of their progressive body absorption, which enables new tissue to develop in their place. Over time, bioresorbable implants may cost less than conventional implants. New and better bioresorbable implants are being created due to increased funding for research and development. These factors expand the market growth.

Threat:

Lack of awareness and education

Surgeons and other medical specialists, as well as physicians generally, might not be very familiar with or knowledgeable about bioresorbable implants. Lack of knowledge may cause reluctance or limited adoption of this more recent technology. Lack of knowledge may cause people to hesitate before using bioresorbable implants or to be reluctant to change accepted norms. However, in comparison to non-resorbable implants, they can be concerned about the strength, longevity, or long-term functioning of these implants. Healthcare providers may be reluctant to suggest or utilise bioresorbable implants without the necessary training and information, which hinders market growth.

COVID-19 Impact

The COVID-19 pandemic had a profound effect on the world market for bioabsorbable implants. The demand for bioresorbable implants was limited as a result of hospitals deferring elective treatments like orthopaedic surgery because of the epidemic. The COVID-19's limitations on how the chemicals and materials industry operates have hurt the worldwide market. Additionally, due to supply chain disruptions and challenges sourcing raw materials, the market for bioresorbable implants has been severely restricted. The market for bioabsorbable implants is anticipated to expand dramatically over the coming years, despite these short-term challenges.

The ceramics segment is expected to be the largest during the forecast period

The ceramics segment is estimated to hold the largest share. Ceramics are inorganic, non-metallic materials with special qualities that make them ideal for certain uses in bioresorbable implants. Ceramics are widely employed in bioresorbable implants because to their superior mechanical strength, biocompatibility, and osteoconductive qualities. Ceramic materials can act as a scaffold for bone re growth and make it easier for the implant to blend in with the surrounding tissue. Bioresorbable implants made of ceramic are frequently utilised in situations where strong mechanical performance and structural support are necessary.

The biological meshes segment is expected to have the highest CAGR during the forecast period

The biological meshes segment is anticipated to have lucrative growth during the forecast period. Implantable materials called "biological meshes" are created using biological resources like human cadaver donors or animal tissues. Extracellular matrix (ECM), which supports structural integrity and aids in tissue integration, is preserved in these meshes' processing and treatment while cellular components are eliminated. The body usually tolerates biological meshes well because they are made of natural materials. Compared to synthetic materials, they are less susceptible to immunological reactions or rejection. The body has the capacity to restructure and eventually resorb biological meshes. A natural mending process is brought about by the mesh gradually deteriorating and being replaced by fresh tissue.

Region with largest share:

North America commanded the largest market share during the extrapolated period owing to factors such as a high prevalence of cardiovascular disease and an increase in the geriatric population, which is expected to increase the number of cases of osteoporosis and osteoarthritis. Moreover, rise in demand for orthopedic implants and continuous development of advanced technologies to improve the clinical performance of contemporary treatment modalities and devices are projected to fuel the growth of the market in North America during the forecast period.

Region with highest CAGR:

Asia-Pacific is expected to witness profitable growth over the projection period due to extensive awareness about the bioresorbable implants; these areas are most likely to be potential markets for bioresorbable implant in the region. The Asia-Pacific region has a large and growing aging population. This is leading to an increase in the number of people with chronic diseases, such as osteoporosis and osteoarthritis. Bioresorbable implants can be used to treat these diseases and improve the quality of life of patients.

Key players in the market:

Some of the key players in the Bioresorbable Implants Market include: Medtronic Plc, Dentsply Shiroma., Boston Scientific Corporation, Meryl Life Sciences Pvt. Ltd., Stryker Corporation, Smith & Nephew Plc, KLS Martin, Wright Medical Group, Biotronik Ltd, Syntellix AG, JW Medical Systems LTD, Q3 Medical Devices Limited., Orbusneich Medical., Depuy Synthes, Bioretec Ltd, Conmed Corporation and Zimmer Biomet Holdings, Inc.

Key Developments:

In September 2022, Biotronik Ltd Announces Collaboration with AliveCor As First In A Series of Strategic Partnerships to Disrupt Cardiac Digital Health With AI-Enabled Solutions. This partnership aims to enable faster diagnosis, more informed clinical decision-making and effective treatment by bringing complete information to every step in the diagnosis, device implant, and management process.

In February 2021, Stryker Corporation and Brainomix announced a new partnership that will represent a transformative solution for stroke networks across EMEA, enabling broader utilization of stroke imaging AI tools to help more patients gain access to life-saving treatments.

Product Types Covered:

  • Stents
  • Biological Meshes
  • Fixation Devices
  • Resorbable Mesh
  • Resorbable Band
  • Resorbable Scaffolds
  • Resorbable Tethers

Material Types Covered:

  • Ceramics
  • Metallic
  • Polymers
  • Other Material Types

Applications Covered:

  • Orthopedics
  • Cardiovascular
  • General Surgery
  • Cosmetic Surgery
  • Cranial
  • Dental Surgery
  • Vascular Surgery

End Users Covered:

  • Specialty Clinics
  • Hospitals
  • Ambulatory Surgical Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Bioresorbable Implants Market, By Product Type

  • 5.1 Introduction
  • 5.2 Stents
    • 5.2.1 Peripheral Artery Stents
    • 5.2.2 Coronary Artery Stents
    • 5.2.3 Non vascular Stents
      • 5.2.3.1 Biliary Stents
      • 5.2.3.2 Esophageal Stents
  • 5.3 Biological Meshes
  • 5.4 Fixation Devices
  • 5.5 Resorbable Mesh
  • 5.6 Resorbable Band
  • 5.7 Resorbable Scaffolds
  • 5.8 Resorbable Tethers

6 Global Bioresorbable Implants Market, By Material Type

  • 6.1 Introduction
  • 6.2 Ceramics
  • 6.3 Metallic
  • 6.4 Polymers
    • 6.4.1 PGA (Polyglycolide)
    • 6.4.2 Co-Polymers
    • 6.4.3 PLA (Polylactide)
  • 6.5 Other Material Types

7 Global Bioresorbable Implants Market, By Application

  • 7.1 Introduction
  • 7.2 Orthopedics
  • 7.3 Cardiovascular
  • 7.4 General Surgery
  • 7.5 Cosmetic Surgery
  • 7.6 Cranial
  • 7.7 Dental Surgery
  • 7.8 Vascular Surgery

8 Global Bioresorbable Implants Market, By End User

  • 8.1 Introduction
  • 8.2 Specialty Clinics
  • 8.3 Hospitals
  • 8.4 Ambulatory Surgical Centers
  • 8.5 Other End Users

9 Global Bioresorbable Implants Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Medtronic Plc
  • 11.2 Dentsply Shiroma.
  • 11.3 Boston Scientific Corporation
  • 11.4 Meryl Life Sciences Pvt. Ltd.
  • 11.5 Stryker Corporation
  • 11.6 Smith & Nephew Plc
  • 11.7 KLS Martin
  • 11.8 Wright Medical Group
  • 11.9 Biotronik Ltd
  • 11.10 Syntellix AG
  • 11.11 JW Medical Systems LTD
  • 11.12 Q3 Medical Devices Limited.
  • 11.13 Orbusneich Medical.
  • 11.14 Depuy Synthes
  • 11.15 Bioretec Ltd
  • 11.16 Conmed Corporation
  • 11.17 Zimmer Biomet Holdings, Inc.

List of Tables

  • Table 1 Global Bioresorbable Implants Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Bioresorbable Implants Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 3 Global Bioresorbable Implants Market Outlook, By Stents (2021-2030) ($MN)
  • Table 4 Global Bioresorbable Implants Market Outlook, By Peripheral Artery Stents (2021-2030) ($MN)
  • Table 5 Global Bioresorbable Implants Market Outlook, By Coronary Artery Stents (2021-2030) ($MN)
  • Table 6 Global Bioresorbable Implants Market Outlook, By Non vascular Stents (2021-2030) ($MN)
  • Table 7 Global Bioresorbable Implants Market Outlook, By Biological Meshes (2021-2030) ($MN)
  • Table 8 Global Bioresorbable Implants Market Outlook, By Fixation Devices (2021-2030) ($MN)
  • Table 9 Global Bioresorbable Implants Market Outlook, By Resorbable Mesh (2021-2030) ($MN)
  • Table 10 Global Bioresorbable Implants Market Outlook, By Resorbable Band (2021-2030) ($MN)
  • Table 11 Global Bioresorbable Implants Market Outlook, By Resorbable Scaffolds (2021-2030) ($MN)
  • Table 12 Global Bioresorbable Implants Market Outlook, By Resorbable Tethers (2021-2030) ($MN)
  • Table 13 Global Bioresorbable Implants Market Outlook, By Material Type (2021-2030) ($MN)
  • Table 14 Global Bioresorbable Implants Market Outlook, By Ceramics (2021-2030) ($MN)
  • Table 15 Global Bioresorbable Implants Market Outlook, By Metallic (2021-2030) ($MN)
  • Table 16 Global Bioresorbable Implants Market Outlook, By Polymers (2021-2030) ($MN)
  • Table 17 Global Bioresorbable Implants Market Outlook, By PGA (Polyglycolide) (2021-2030) ($MN)
  • Table 18 Global Bioresorbable Implants Market Outlook, By Co-Polymers (2021-2030) ($MN)
  • Table 19 Global Bioresorbable Implants Market Outlook, By PLA (Polylactide) (2021-2030) ($MN)
  • Table 20 Global Bioresorbable Implants Market Outlook, By Other Material Types (2021-2030) ($MN)
  • Table 21 Global Bioresorbable Implants Market Outlook, By Application (2021-2030) ($MN)
  • Table 22 Global Bioresorbable Implants Market Outlook, By Orthopedics (2021-2030) ($MN)
  • Table 23 Global Bioresorbable Implants Market Outlook, By Cardiovascular (2021-2030) ($MN)
  • Table 24 Global Bioresorbable Implants Market Outlook, By General Surgery (2021-2030) ($MN)
  • Table 25 Global Bioresorbable Implants Market Outlook, By Cosmetic Surgery (2021-2030) ($MN)
  • Table 26 Global Bioresorbable Implants Market Outlook, By Cranial (2021-2030) ($MN)
  • Table 27 Global Bioresorbable Implants Market Outlook, By Dental Surgery (2021-2030) ($MN)
  • Table 28 Global Bioresorbable Implants Market Outlook, By Vascular Surgery (2021-2030) ($MN)
  • Table 29 Global Bioresorbable Implants Market Outlook, By End User (2021-2030) ($MN)
  • Table 30 Global Bioresorbable Implants Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 31 Global Bioresorbable Implants Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 32 Global Bioresorbable Implants Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 33 Global Bioresorbable Implants Market Outlook, By Other End Users (2021-2030) ($MN

)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.